Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
san francisco top stories
2
×
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
cannabidiol
celgene
charges
clinical trials
congress
crisis
detroit blog main
detroit top stories
dravet syndrome
drug prices
drugs
easl
epidiolex
fatty liver disease
fda
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
house of representatives
indiana blog main
indiana top stories
indivior
insulin
What
drug
form
2
×
advanced
ago
alnylam’s
approval
approved
battle
bff
bio
cannabis
conference
data
deals
derivative
devoted
disease
easl
epilepsy
fda
gene
gw
gw’s
kicked
liver
major
marijuana
market
medicine
pharmaceuticals
race
rare
roundup
sets
therapy
treat
updates
weeks
world's
zogenix
Language
Current search:
form
×
" san francisco top stories "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug